发明名称 |
Assays and methods of treatment relating to vitamin D insufficiency |
摘要 |
Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency. |
申请公布号 |
US9217748(B2) |
申请公布日期 |
2015.12.22 |
申请号 |
US201213978193 |
申请日期 |
2012.01.06 |
申请人 |
The General Hospital Corporation;Beth Israel Deaconess Medical Center, Inc. |
发明人 |
Thadhani Ravi;Karumanchi S. Ananth;Berg Anders Hayden;Bhan Ishir |
分类号 |
G01N31/00;G01N33/53;G01N33/82 |
主分类号 |
G01N31/00 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A method for determining a level of bioavailable vitamin D and a level of free vitamin D in a subject, the method comprising:
performing assays on a blood sample obtained from the subject to determine a level of VDBP (vitamin D binding protein) polypeptide, albumin polypeptide and total vitamin D; calculating a level of bioavailable vitamin D, wherein a level of bioavailable vitamin D is:
=(Kalb*[Alb]+1)*[Free Vitamin D] and calculating a level of free vitamin D, wherein a level of free vitamin D is:
={−{KDBP·[Total DBP]−KDBP·[Total Vitamin D]+Kalb·[Alb]+1}+√{(KDBP·[Total DBP]−KDBP·[Total Vitamin D]+Kalb·[Alb]+1)2+4·(KDBP·Kalb·[Alb]+KDBP)·([Total Vitamin D])}}÷(2·{KDBP·Kalb·[Alb]+KDBP}). |
地址 |
Boston MA US |